Clear USP with strong corporate partners in the background

We deliver Good Manufacturing Practice (GMP) every day!

HALIX is a leading player in the field of contract manufacturing. Supported by strong stable partners throughout the complete value chain. We offer the complete service range to commercialize biopharmaceutical products. At the same time, we ensure GMP throughout all steps in the process.

State of the art GMP facilities ensure manufacturing capabilities with the highest quality standards. These facilities allow for the production of recombinant proteins and virus up to BSL2 level. Clients benefit from 55 years of experience in biopharmaceutical manufacturing. The Dutch health authorities have inspected and approved our processes.

We are able to start your project today

HALIX is the preferred partner for GMP manufacturing projects in bioscience:

    Flexible approach of projectsResult- and quality-driven cultureShort communication linesWide range of services



HAL Allergy Holding B.V. is the 100% shareholder of HALIX B.V. Both are a subsidiary of the family owned Droege Group International AG

Droege Group was founded in 1988. It is an independent Advisory and Investment Company based in Düsseldorf, Germany. Since 25 years, the Group is a specialist for customized transformation programs. Its aim is value enhancement. Droege Group employs its own funds to carry out direct investments. It invests in corporate subsidiaries and medium-sized enterprises. The goal is to hold and develop investments in the long run. The group achieves this via buy & build strategies ("Corporate Entrepreneurship"). Droege Group engages with equity in companies. It offers the same approach as a service provider in customized Value-add engagements. This is "Entrepreneurship as a Service". USP of the business model is Know-how + capital + management from one single source. The family-owned company has a domestic and international market position. It enjoys a high reputation and operates in over 30 countries worldwide.

More information: